Impact of Erythropoietin in the management of Hypoxic Ischaemic Encephalopathy in resource-constrained settings: protocol for a randomized control trial.

Beatrice Nkolika EzenwaChinyere EzeakaIretiola FajoluAnne OgbennaOmodele OlowoyeyeObiyo NwaiwuZainab OpoolaGbenga Olorunfemi

Published in: BMC neurology (2020)

The study has been registered with the Pan African Clinical trials registry on the 2nd of December 2018, with registration number PACTR201812814507775.

Keyphrases

clinical trial
randomized controlled trial
early onset
recombinant human
phase ii
double blind